Live antiviral updates

Live antiviral news coverage of developments with the latest updates. Stay on top of latest antiviral news stories and find out what just happened, what is going on with antiviral. The latest real-time news updates and headlines on antiviral
COVID made things taste weird, now ‘Paxlovid mouth’ sounds disgusting
Vaccinia virus MacGyvers makeshift tool to repair its DNA, exposing vulnerability
Rutgers Recruiting Participants for Pfizer Pediatric Oral Antiviral Covid Treatment Clinical Trial
Unique binding of Delta variant may explain high transmissibility
Blocking spike captors to counter COVID
PAXLOVID Oral Covid treatment available on Pharmaceutical Benefits Scheme from 1 May
Living better with severe asthma and allergy
WHO recommends Covid drug and urges transparency around pricing
WHO recommends highly successful Covid therapy and calls for wide geographical distribution and transparency from originator
Can nanotechnology help fight viruses?
Scientists Develop Indoor-active Photocatalyst for Antiviral Coating Against Various Variant Types of Novel Coronavirus SARS-CoV-2
Researchers develop indoor-active photocatalyst for antiviral coating against various variant types of novel coronavirus Covid
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Immune system culprit in severe COVID cases found
SARS-CoV-2 virus can infect heart’s pacemaker cells
Materials – Self-sanitizing N95 masks
New guidance sets out how to live safely with Covid
Proclamation on National Public Health Week, 2022
Are Covid-linked arrhythmias caused by viral damage to heart’s pacemaker cells?
Better understanding Covid
NIH experts discuss controlling Covid in commentary on herd immunity
Scaffold with twist: Cryo-EM reveals building blocks of poxvirus
Cryo-EM finds building blocks of poxvirus
Changes to Covid testing in England from 1 April
Research reveals effectiveness of pill form of remdesivir to treat Covid
No-Click System Doubles Hepatitis C Screening Orders, Penn Study Finds
First Participants dosed in ENA Respiratory’s phase 2a study
Targeting viral lung infections two ways
Elevated inflammation persists in immune cells months after mild Covid
Patented molecules that counteract effect of most common anticoagulant drug
Pfizer Initiates Phase 2/3 Study of Novel Covid Oral Treatment in Pediatric Participants
Human CD8+ T cell subset that suppresses pathogenic CD4+ T cells in autoimmune and infectious diseases
Calming cytokine storm: Harnessing power of stem cells to improve survival in ‘sickest of sick’ Covid patients
UN health agency updates guidelines on Covid therapeutics
WHO recommends antiviral drug for patients with non-severe Covid at highest risk of hospital admission
Significant reduction in deaths from hepatitis C in England, UKHSA reports
WHO updates its treatment guidelines to include molnupiravir
Can amino acid also be developed as pesticide against plant viruses?
First Covid pill funded through PBS
Fighting Covid with milk?
Bark of Neem Tree May Protect Against Coronavirus Variants
Recently identified protein group plays major role in nature
Versatile synthesis of organic compounds from ascorbic acid
Helping body overcome Covid
Promising molecule for treatment of Covid
Existing drug may protect against COVID lung injury
Novel synthetic process for core structure of fungal antiviral agent Neoechinulin B and its derivatives
Old drug may have new trick